Health Condition 1: O- Medical and Surgical Health Condition 2: L80- Vitiligo
Conditions
Interventions
Intervention1: IMMUNOMODULATORS WITH NON-CULTURED EPIDERMAL CELL SUSPENSION: After proper history and clinical examination , patients with more than 3 months of patch stability (denovo/induced stabili
Sponsors
AIIMS JODHPUR
Eligibility
Inclusion criteria
Inclusion criteria: 1) More than 3 months of patch stability (spontaneous or therapy induced) 2) Subjects with non-segmental /segmental vitiligo 3) Age =15 years
Exclusion criteria
Exclusion criteria: 1. Unstable for last 3 months 2. Universal vitiligo or exclusive involvement of tip of finger, toes or palmo plantar or genitalia 3. Vitiligo Patch size more than 100 cm2size 4. Pregnancy or lactation 5. Patients with bleeding diathesis or keloidal tendencies 6. Any known hypersensitivities or contraindication to immunomodulators or local anesthesia 7. Presence of any of the following : Immunocompromised patient, malignancy, co-morbidities like uncontrolled diabetes, chronic renal disease, chronic kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Repigmentation: a. Objective – Investigator global assessment (IGA) Vitiligo area severity index (VASI), Colour match, pattern of repigmentation, Dermoscopic assessment (BPLeFoSK criteria) b. Subjective - Patient global assessment (PGA) 2)Investigator Global Assessment (IGA) Patient Global Assessment (PGA) Timepoint: At baseline, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks and 24 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Side effects will be noted 2 VIS-22 score assessment for quality of life Timepoint: At Baseline,4 weeks,8 weeks,12 weeks,16 weeks,20 weeks,24 weeks | — |
Countries
India
Contacts
Public ContactDr Sabyasachi Debata
AIIMS JODHPUR
Outcome results
None listed